SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-97-000919
Filing Date
1997-02-10
Accepted
1997-02-10 00:00:00
Documents
1
Group Members
JOHNSON & JOHNSONJOHNSON & JOHNSON DEVELOPMENT CORPORATION
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 10208
  Complete submission text file 0000950123-97-000919.txt   12123
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 9085240400
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043 4154281550
MICROCIDE PHARMACEUTICALS INC (Subject) CIK: 0001010915 (see all company filings)

IRS No.: 943186021 | State of Incorp.: CA
Type: SC 13G | Act: 34 | File No.: 005-47911 | Film No.: 97521703
SIC: 2834 Pharmaceutical Preparations